BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1801843)

  • 1. Inhibited neoplastic phenotype by the c-Ha-ras antisense RNA.
    Lu GR; Wu CJ; Ke Y; Xiong X; Li YJ; Liu JM; Xu Y; Xu W; Li JY; Deng GR
    Sci China B; 1991 Dec; 34(12):1485-91. PubMed ID: 1801843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antisense c-Ha-ras oligodeoxynucleotides inhibit the proliferation of the gastrocarcinoma-DNA-transformed rat 3-3 cells and reduce the p21 expression of the cells.
    Xu Y; Deng GR; Liang YY; Li C
    Sci China B; 1991 Jan; 34(1):35-41. PubMed ID: 2015062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The relationship between metastatic phenotype and steady expression of BGC-Ha-ras oncogene from metastasis cell lines in nude mice (abstract)].
    Li YJ
    Zhonghua Zhong Liu Za Zhi; 1992 Nov; 13(6):402-5. PubMed ID: 1349521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD; Hernandez OM; Hebel D; Root M; Pow-Sang JM; Wickstrom E
    Cancer Res; 1993 Feb; 53(3):577-80. PubMed ID: 8425190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhibitory effect of monoclonal antibody PD4 on Ha-ras transformed cells Rat3-3].
    Yin WN
    Zhonghua Zhong Liu Za Zhi; 1991 Mar; 13(2):82-6. PubMed ID: 1879298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
    Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
    Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inhibition of antisense DNA and its derivative on gastric transformed cell carcinogenicity].
    Yang D; Li T; Xu W
    Zhonghua Wai Ke Za Zhi; 1995 Jan; 33(1):26-8. PubMed ID: 7774440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.
    Mukhopadhyay T; Tainsky M; Cavender AC; Roth JA
    Cancer Res; 1991 Mar; 51(6):1744-8. PubMed ID: 1998965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased cell-substrate adhesion accompanies conditional reversion to the normal phenotype in ras-oncogene-transformed NIH-3T3 cells.
    Shumaker DK; Sklar MD; Prochownik EV; Varani J
    Exp Cell Res; 1994 Oct; 214(2):440-6. PubMed ID: 7925639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on inhibition of activated oncogene expression by antisense RNA].
    Yang Q; Sun B; Chen Y; Dong Y; Chen D
    Yi Chuan Xue Bao; 1996; 23(3):243-8. PubMed ID: 8950853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L; Pitkänen K; Laiho M
    Oncogene; 1993 Oct; 8(10):2703-11. PubMed ID: 8378082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites.
    Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE
    Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Reversal of malignant phenotype of human hepatoma cells by antisense c-ets-2, c-myc and N-ras].
    Huang XM; Wei SG; Wang LF
    Zhonghua Zhong Liu Za Zhi; 1994 Jul; 16(4):243-6. PubMed ID: 7805549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of Ha-ras oncogene on cells immortalized by the gene for polyomavirus large T-antigen].
    Komissarova EV; Spitkovskiĭ DD; Mazurenko NN; Tatosian AG
    Mol Gen Mikrobiol Virusol; 1990 Feb; (2):19-22. PubMed ID: 2185418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines.
    Wang B; Soule HD; Miller FR
    Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of pancreatic cancer by the dominant negative ras mutant, N116Y.
    Shichinohe T; Senmaru N; Furuuchi K; Ogiso Y; Ishikura H; Yoshiki T; Takahashi T; Kato H; Kuzumaki N
    J Surg Res; 1996 Dec; 66(2):125-30. PubMed ID: 9024823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
    Wang XY; Repasky E; Liu HT
    Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced Ha-ras oncogene products.
    Caulín C; López-Barcons L; Gonzáles-Garrigues M; Navarro P; Lozano E; Rodrigo I; Gamallo C; Cano A; Fabra A; Quintanilla M
    Mol Carcinog; 1996 Feb; 15(2):104-14. PubMed ID: 8599577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The inhibitory effect of antisense--RNA of papillomavirus type 16 E6E7 genes on malignant phenotypes of cervical carcinoma cell line].
    Ming L; Zhou L; Shang M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):54-7. PubMed ID: 12515173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.